|
Sounds like there are a number of advocacy organizations to go through. I am certain that we could start a letter writing campaign to Genetech asking them to start a new trial for heavily pretreated her2+ metastatic breast cancer. If this is needed I am sure we can whip up the masses to make sure Genetech and the FDA hears a loud voice. This worked for HIV antivirals. Why not in this case?
|